Mimedx (MDXG) Total Debt Growth (3y) (2019 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Total Debt Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | -10.56% |
| 10 | Mimedx | 671.73 Mn | 535.89 Mn | 44.38 Mn | -29.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.37% |
| Mar 31, 2026 | -28.79% |
| Dec 31, 2025 | -28.23% |
| Sep 30, 2025 | -27.84% |
| Jun 30, 2025 | -27.46% |
| Mar 31, 2025 | -27.14% |
| Dec 31, 2024 | -26.86% |
| Sep 30, 2024 | -25.26% |
| Jun 30, 2024 | -25.77% |
| Mar 31, 2024 | -27.00% |
| Dec 31, 2023 | 0.97% |
| Sep 30, 2023 | -0.69% |
| Jun 30, 2023 | -13.60% |
| Mar 31, 2023 | -13.76% |
| Dec 31, 2022 | -9.54% |
| Sep 30, 2022 | -14.59% |
| Jun 30, 2022 | -15.00% |
| Jun 30, 2020 | 62.72% |
| Mar 31, 2020 | 105.58% |
| Dec 31, 2019 | 99.57% |